Evaluate SLN360 in participants with elevated Lp(a) at high risk of atherosclerotic cardiovascular disease events (ALPACAR-360, NCT05537571)

Educational Partners and Supporters

(Founding Partner)

Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.